Poornima Mahavadi
Giessen, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Tidal Volume in Idiopathic Pulmonary Fibrosis: Restriction Severity and Prognostic Information Beyond Forced Vital Capacity.
Journal: Respiration; international review of thoracic diseases
Published: May 14, 2026
Sex-Dependent Integration of Symptoms and Functional Vulnerability in Interstitial Lung Disease: eurILDreg Study.
Journal: Respiration; international review of thoracic diseases
Published: February 06, 2026
The Patient Journey in Interstitial Lung Disease: Mobility, Independence, and Psychological Burden.
Journal: Journal of clinical medicine
Published: November 12, 2025
Targeting fused in sarcoma (FUS): a novel antisense strategy for treating idiopathic pulmonary fibrosis.
Journal: Signal transduction and targeted therapy
Published: August 22, 2025
RAAS antagonists dampen the SARS-CoV-2 infection in ex-vivo cultured human precision-cut lung slices.
Journal: Respiratory research
Published: May 15, 2025
LTI-03 peptide demonstrates anti-fibrotic activity in ex vivo lung slices from patients with IPF.
Journal: iScience
Published: March 12, 2025
Protocol and research program of the European registry and biobank for interstitial lung diseases (eurILDreg).
Journal: BMC pulmonary medicine
Published: August 14, 2024
Pre-clinical proof-of-concept of anti-fibrotic activity of caveolin-1 scaffolding domain peptide LTI-03 in ex vivo precision cut lung slices from patients with Idiopathic Pulmonary Fibrosis.
Journal: bioRxiv : the preprint server for biology
Published: May 07, 2024
BAG3: An enticing therapeutic target for idiopathic pulmonary fibrosis.
Journal: Journal of cellular biochemistry
Published: January 31, 2023
Notch1 Induces Defective Epithelial Surfactant Processing and Pulmonary Fibrosis.
Journal: American journal of respiratory and critical care medicine
Published: September 01, 2022
Last Updated: 09/26/2026